Insiders Palisade Bio, Inc.

Equities

SNCA

US6963894026

Delayed Nasdaq Other stock markets 02:00:28 2024-05-10 pm EDT			5-day change	1st Jan Change
6.756 ^USD	-2.65%		-12.72%	-23.66%

May. 07	Palisade Bio, Inc. Appoints Margery Fischbein to Its Board of Directors	CI
May. 01	Wall Street Set to Open Lower Ahead of Fed Rate Decision; Private Employment Figures Top Forecasts	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Palisade Bio, Inc. Appoints Margery Fischbein to Its Board of Directors	May. 07	CI
Palisade Bio, Inc. Announces Resignation of Mary Ann Gray as Member of the Board	Mar. 06	CI
Palisade Bio Names Donald Williams as Chairman	Feb. 13	MT
Palisade Bio, Inc. Announces Advisory Board Appointments	Feb. 08	CI
Palisade Bio, Inc. Announces the Appointment of Mitchell Jones, M.D., Ph.D., as Chief Medical Officer	23-09-11	CI
Palisade Bio, Inc. Appoints Mitchell Jones as Chief Medical Officer	23-09-11	CI
Palisade Bio, Inc. Announces Board Appointments	23-02-08	CI
Palisade Bio Appoints Herbert B. Slade MD, FAAAAI as Chief Medical Officer	22-11-18	CI
Palisade Bio, Inc. Terminates Michael Dawson as Chief Medical Officer	22-10-17	CI
Palisade Bio, Inc. Announces Executive Changes	22-10-14	CI
Palisade Bio CEO Thomas Hallam Resigns; CFO JD Finley Named Interim Replacement; Shares Fall	22-10-11	MT
Palisade Bio, Inc. Announces Chief Executive Officer Changes	22-10-11	CI
Palisade Bio, Inc. Appoints Robert McRae as Senior Vice President, Operations and Strategic Development	22-02-15	CI
Palisade Bio, Inc. Launches Clinical Steering Committee	21-06-15	CI
Seneca Biopharma, Inc. Announces Board Changes	21-04-27	CI
Palisade Bio, Inc. Announces Board Changes	21-04-26	CI
Seneca Biopharma, Inc. Announces Appointment of Dane Saglio as Principal Executive Officer	21-03-18	CI
Seneca Biopharma, Inc. Announces Management Changes	21-03-18	CI
Thomas Hallam to Serve as Chief Executive Officer of Seneca Biopharma, Inc	20-12-21	CI
Seneca Biopharma, Inc. Announces Executive Appointments and Key Promotion	20-04-01	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Palisade Bio, Inc.

Equities

SNCA

US6963894026

Insiders

Filters